Laurel Todd

Laurel Todd

Company: IOVANCE Biotherapeutics

Job title: Vice President, US Market Access & Policy

Bio:

Laurel has been involved in the pricing and reimbursement for novel therapies from both a commercial and policy perspective for over a decade.

Seminars:

Panel Discussion: Designing a Clinical Development Program to Support Future Market Access 4:55 pm

What are the critical market access steps when entering the clinic? Bridging the gap between early-phase development and commercial: ensuring relevant payer and patient endpoints are a consideration in all phases of study design Practical advice when designing a clinical program for an intended first-in-class therapy Does engagement with Medicare look the same as commercial…Read more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.